1. Clinical and economic impact of a switch from high- to low-volume renal replacement therapy in patients with acute kidney injury
- Author
-
A. L. Paterson, D. Kingston, A. J. Johnston, and R. Mahroof
- Subjects
Adult ,Male ,medicine.medical_specialty ,Continuous haemodiafiltration ,Adolescent ,Critical Care ,medicine.medical_treatment ,Hemodiafiltration ,Kidney Function Tests ,law.invention ,Cohort Studies ,Young Adult ,Cost Savings ,law ,Intensive care ,Internal medicine ,medicine ,Humans ,In patient ,Hospital Mortality ,Renal replacement therapy ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Acute kidney injury ,Retrospective cohort study ,Recovery of Function ,Acute Kidney Injury ,Length of Stay ,Middle Aged ,medicine.disease ,Survival Analysis ,Intensive care unit ,Surgery ,Renal Replacement Therapy ,Low volume ,Intensive Care Units ,Treatment Outcome ,Anesthesiology and Pain Medicine ,Female ,business - Abstract
Summary High-intensity renal replacement therapy protocols in intensive care patients with acute kidney injury have failed to translate to improved patient outcomes when compared with lower-intensity protocols. This retrospective study explored the clinical and economic impacts of switching from a 30–35 ml.kg−1.h−1 (high-volume) to a 20 ml.kg−1.h−1 (low-volume) protocol. Patients (n = 366) admitted 12 months before (n = 187) and after (n = 179) the switch were included in the study. There was no difference in in-hospital mortality (77/187 (41%) vs 75/179 (42%), respectively, p = 0.92), intensive care unit mortality (55/187 (29%) vs 61/179 (34%), respectively, p = 0.40), duration of organ support or extent of renal recovery between the high- and low-volume cohorts. A 25% reduction in daily replacement fluid usage was observed, equating to a cost saving of over £27 000 per annum. In conclusion, a switch from high- to low-volume continuous haemodiafiltration had minimal effects on clinical outcomes and resulted in marked cost savings.
- Published
- 2014